Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection
- 1 January 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (2) , 275-277
- https://doi.org/10.1097/00002030-200101260-00020
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Antiretroviral Therapy in AdultsJAMA, 2000
- Highly Active Antiretroviral Treatment Initiated Early in the Course of Symptomatic Primary HIV‐1 Infection: Results of the ANRS 053 TrialThe Journal of Infectious Diseases, 1999
- Rate of HIV-1 RNA rebound upon stopping antiretroviral therapyAIDS, 1999
- Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral TherapyNew England Journal of Medicine, 1999
- Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatmentAIDS, 1999
- The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune ResponsesThe Journal of Infectious Diseases, 1999